dimethyl fumarate mylan
mylan ireland limited - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethylfumarat 1a pharma 120 mg - magensaftresistente hartkapseln
1a pharma gmbh - dimethylfumarat -
dimethylfumarat 1a pharma 240 mg - magensaftresistente hartkapseln
1a pharma gmbh - dimethylfumarat -
dimtruzic 120 mg - magensaftresistente hartkapseln
sandoz gmbh - dimethylfumarat -
dimtruzic 240 mg - magensaftresistente hartkapseln
sandoz gmbh - dimethylfumarat -
dimethyl fumarate teva
teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethylfumarat stada 120 mg magensaftresistente hartkapseln
stada arzneimittel gmbh - dimethylfumarat -
dimethylfumarat stada 240 mg magensaftresistente hartkapseln
stada arzneimittel gmbh - dimethylfumarat -